![]() |
市場調查報告書
商品編碼
1813378
2032 年超音波手術刀市場預測:按產品、可用性、應用、最終用戶和地區進行的全球分析Ultrasonic Scalpel Market Forecasts to 2032 - Global Analysis By Product, Usability, Application, End User and By Geography |
根據 Stratistics MRC 的數據,全球超音波手術刀市場預計在 2025 年達到 25.1 億美元,到 2032 年將達到 47.5 億美元,預測期內的複合年成長率為 9.5%。
超音波手術刀是一種利用高頻超音波振動同時切割和凝固組織的手術器械。其工作原理是將電能轉化為機械運動,產生快速的刀片振動,並透過摩擦產生局部熱量。這不僅能實現精確解剖,還能最大限度地減少對周圍組織的熱損傷。超音波手術刀常用於腹腔鏡和開放性手術,能夠改善止血效果、減少出血並提高手術區域的可視性,使其成為現代微創手術中的重要工具。
微創手術(MIS)的需求不斷增加
超音波手術刀正成為各專業微創手術方案的重要組成部分,能夠以最小的熱損傷實現精確的組織解剖。隨著手術效果的改善以及醫療系統尋求降低手術成本,對超音波手術刀等先進能量器材的需求持續飆升。隨著人們日益重視以患者為中心的照護以及手術器械技術的進步,這一趨勢進一步加劇。這些技術可以減輕術後疼痛、縮短住院時間並加快復健速度,對患者和醫療機構都極具吸引力。
替代手術技術的可用性
在某些外科手術情況下,超音波手術刀的替代技術具有顯著優勢,這可能會限制超音波解決方案的普及。此外,醫院和手術中心在選擇設備時,通常優先考慮成本效益以及與現有基礎設施的兼容性,這可能會阻礙其市場滲透。此外,集切割、凝固和封閉功能於一體的多功能設備的出現,也對獨立超音波系統構成了挑戰。
門診手術中心的興起
ASC 優先考慮效率、成本控制和微創手術,這與超音波設備的功能高度契合。這些中心擴大在傳統醫院環境之外進行複雜的手術,這推動了對緊湊、可靠且易於使用的設備的需求。此外,優惠的報銷政策和對門診護理的監管支持正在鼓勵對先進外科技術的投資。隨著 ASC 數量和規模的不斷擴大,這為製造商擴大市場覆蓋範圍並為高通量環境客製化解決方案提供了重要機會。
供應鏈中斷與貿易政策
全球供應鏈的不穩定和不斷變化的貿易政策給超音波手術刀市場帶來了重大風險。購買專用零件(包括壓電材料和精密加工的刀片)容易受到延誤和成本波動的影響。地緣政治緊張局勢、出口管制和監管變化可能會進一步加劇國際分銷和製造業務的複雜性。此外,依賴第三方供應商提供關鍵零件會增加品管問題和物流瓶頸的風險。
新冠疫情對超音波手術刀市場產生了雙重影響,最初擾亂了手術量和供應鏈,但隨後加速了向微創手術的轉變。在疫情高峰期,擇期手術被推遲,導致器械利用率暫時下降。然而,隨著醫療體系的調整,人們重新重視高效、低風險的手術,並青睞超音波手術刀等能夠縮短手術時間、減少術後併發症的技術。疫情也凸顯了感染控制的重要性,促使醫院投資支持精準和安全的先進工具。
超音波手術刀系統預計將成為預測期內最大的細分市場
超音波手術刀系統憑藉其多功能性和臨床有效性,預計將在預測期內佔據最大的市場佔有率。超音波手術刀系統憑藉其卓越的切割和凝固能力,成為從一般外科到腫瘤外科等各種手術的必備工具。其能夠最大限度地減少組織損傷和失血,從而改善手術效果,並因此被廣泛採用。人體工學設計、能量調節以及刀片技術的不斷創新,進一步提升了其吸引力。
預計預測期內整形外科的複合年成長率最高
預計整形外科領域將在預測期內實現最高成長率,這反映了骨骼和軟組織手術對精密工具日益成長的需求。超音波手術刀因其能夠實現乾淨的切割且熱損傷最小,在關節重建、脊椎手術和創傷治療中的應用日益廣泛。肌肉骨骼疾病的增加、人口老化以及運動相關傷害正在推動整形外科手動手術的增加。此外,超音波技術與機器人技術和導航系統的結合提高了手術精度,使其成為骨科醫生的首選。
預計北美將在預測期內佔據最大的市場佔有率,這得益於其先進的醫療基礎設施、較高的手術量以及主要行業參與者的強大影響力。該地區受益於創新外科技術的早期採用以及對研發的大力投入。優惠的報銷框架和嚴格的監管標準也推動了器械部署的品質和安全。此外,癌症和心血管疾病等需要外科手術介入的慢性疾病的發生率不斷上升,也支撐了超音波手術刀的持續需求。
預計亞太地區將在預測期內實現最高的複合年成長率,這得益於醫療保健涵蓋範圍的擴大、手術需求的不斷成長以及政府主導的現代化舉措。中國、印度和韓國等國家在醫療旅遊業蓬勃發展和基礎設施改善的推動下,微創手術正在快速成長。本土製造商正憑藉經濟高效的解決方案進入市場,而跨國公司則正在投資建立區域合作夥伴關係,以發掘新的商機。老化和都市化等人口趨勢也推動了手術數量的成長。
According to Stratistics MRC, the Global Ultrasonic Scalpel Market is accounted for $2.51 billion in 2025 and is expected to reach $4.75 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Ultrasonic scalpel is a surgical instrument that utilizes high-frequency ultrasonic vibrations to simultaneously cut and coagulate tissue. It operates by converting electrical energy into mechanical motion, producing rapid blade oscillations that generate localized heat through friction. This enables precise dissection with minimal thermal damage to surrounding structures. Commonly used in laparoscopic and open procedures, ultrasonic scalpels offer improved hemostasis, reduced blood loss, and enhanced visibility in the surgical field, making them valuable tools in modern minimally invasive surgery.
Growing demand for minimally invasive surgeries (MIS)
Ultrasonic scalpels, which enable precise tissue dissection with minimal thermal damage, are becoming integral to MIS protocols across specialties. As surgical outcomes improve and healthcare systems aim to lower procedural costs, demand for advanced energy-based instruments like ultrasonic scalpels continues to surge. The trend is further supported by growing awareness of patient-centric care and technological advancements in surgical instrumentation. These techniques offer reduced post-operative pain, shorter hospital stays, and faster recovery times, making them highly attractive to both patients and healthcare providers.
Availability of alternative surgical technologies
Ultrasonic Scalpel alternatives offer distinct benefits in specific surgical contexts, potentially limiting the adoption of ultrasonic solutions. Moreover, hospitals and surgical centers often weigh cost-effectiveness and compatibility with existing infrastructure when selecting equipment, which can hinder market penetration. The availability of multifunctional devices that combine cutting, coagulation, and sealing capabilities also poses a challenge to standalone ultrasonic systems.
Growing number of ambulatory surgery centers
ASCs prioritize efficiency, cost control, and minimally invasive procedures, aligning well with the capabilities of ultrasonic devices. These centers are increasingly performing complex surgeries outside traditional hospital settings, driving demand for compact, reliable, and easy-to-use instruments. Additionally, favorable reimbursement policies and regulatory support for outpatient care are encouraging investment in advanced surgical technologies. As ASCs continue to grow in number and scope, they represent a significant opportunity for manufacturers to expand their market footprint and tailor solutions for high-throughput environments.
Supply chain disruptions and trade policies
Global supply chain instability and evolving trade policies pose notable risks to the ultrasonic scalpel market. The sourcing of specialized components, including piezoelectric materials and precision-engineered blades, is susceptible to delays and cost fluctuations. Geopolitical tensions, export restrictions, and regulatory changes can further complicate international distribution and manufacturing operations. In addition, reliance on third-party suppliers for critical parts increases exposure to quality control issues and logistical bottlenecks.
The COVID-19 pandemic had a dual impact on the ultrasonic scalpel market, initially disrupting surgical volumes and supply chains, but later accelerating the shift toward minimally invasive procedures. Elective surgeries were postponed during peak infection periods, leading to a temporary decline in device utilization. However, as healthcare systems adapted, there was renewed emphasis on efficient, low-risk surgical interventions favoring technologies like ultrasonic scalpels that reduce operating time and post-operative complications. The pandemic also underscored the importance of infection control, prompting hospitals to invest in advanced tools that support precision and safety.
The ultrasonic scalpel systems segment is expected to be the largest during the forecast period
The ultrasonic scalpel systems segment is expected to account for the largest market share during the forecast period driven by its versatility and clinical efficacy. These systems offer superior cutting and coagulation performance, making them indispensable in procedures ranging from general surgery to oncology. Their ability to minimize collateral tissue damage and reduce blood loss enhances surgical outcomes, contributing to widespread adoption. Continuous innovation in ergonomic design, energy modulation, and blade technology is further strengthening their appeal.
The orthopedic surgery segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the orthopedic surgery segment is predicted to witness the highest growth rate reflecting growing demand for precision tools in bone and soft tissue procedures. Ultrasonic scalpels are increasingly used in joint replacement, spinal surgery, and trauma care due to their ability to perform clean cuts with minimal thermal injury. The rise in musculoskeletal disorders, aging populations, and sports-related injuries is fueling procedural volumes in orthopedics. Moreover, the integration of ultrasonic technology with robotic and navigation systems is enhancing surgical accuracy, making it a preferred choice among orthopedic surgeons.
During the forecast period, the North America region is expected to hold the largest market share owing to its advanced healthcare infrastructure, high surgical volumes, and strong presence of key industry players. The region benefits from early adoption of innovative surgical technologies and robust investment in research and development. Favorable reimbursement frameworks and stringent regulatory standards also drive quality and safety in device deployment. Additionally, the growing prevalence of chronic conditions requiring surgical intervention such as cancer and cardiovascular diseases supports sustained demand for ultrasonic scalpels.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR propelled by expanding healthcare access, rising surgical demand, and government-led modernization initiatives. Countries like China, India, and South Korea are witnessing rapid growth in minimally invasive procedures, supported by increasing medical tourism and infrastructure development. Local manufacturers are entering the market with cost-effective solutions, while global players are investing in regional partnerships to tap into emerging opportunities. The region's demographic trends, including aging populations and urbanization, are contributing to higher surgical caseloads.
Key players in the market
Some of the key players in Ultrasonic Scalpel Market include Johnson & Johnson, Medtronic plc, Olympus Corporation, Stryker Corporation, Misonix Inc., BOWA-electronic GmbH & Co. KG, Axon Medical Solutions, Wuhan BBT Medical Tech Co., Ltd., Reach Surgical Inc., Innolcon Medical Technology, InnoSound Technologies Inc., Heal Force Bio-Meditech Holdings, DePuy Synthes (J&J), ConMed Corporation, NSK Ltd., and Boston Scientific Corporation.
In July 2025, Innolcon completed pilot production of ultrasonic scalpels at its Hefei facility. This milestone supports domestic innovation in energy-based surgical systems. It reflects Innolcon's expansion into ophthalmic and laparoscopic robotics.
In April 2025, Axon unveiled new fixed license plate recognition cameras and AI-powered safety tools. These additions expand its real-time public safety ecosystem. The launch supports drone integration and automated alerts.
In January 2025, BBT Medical acquired a distribution business in Chile to expand its LATAM footprint. The move strengthens its minimally invasive surgical systems portfolio. It aligns with BBT's global strategy for ultrasonic and RF platforms.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.